Gelstat Corp. (GSAC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
GSAC Profit Margin, ROE & Profitability Analysis
GSAC vs Healthcare Sector: How Gelstat Corp. Compares
How Gelstat Corp. compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Gelstat Corp. Stock Overvalued? GSAC Valuation Analysis 2026
Based on fundamental analysis, Gelstat Corp. has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Gelstat Corp. Balance Sheet: GSAC Debt, Cash & Liquidity
GSAC Revenue Growth, EPS Growth & YoY Performance
GSAC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Gelstat Corp. (CIK: 0000890725)
📋 Recent SEC Filings
❓ Frequently Asked Questions about GSAC
What is the AI rating for GSAC?
Gelstat Corp. (GSAC) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are GSAC's key strengths?
Claude: Analysis in progress.
What are the risks of investing in GSAC?
Claude: Analysis in progress.
What is GSAC's revenue and growth?
Gelstat Corp. reported revenue of N/A.
Does GSAC pay dividends?
Gelstat Corp. does not currently pay dividends.
Where can I find GSAC SEC filings?
Official SEC filings for Gelstat Corp. (CIK: 0000890725) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is GSAC's EPS?
Gelstat Corp. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is GSAC's fundamental grade?
Based on our AI fundamental analysis in May 2026, Gelstat Corp. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is GSAC stock overvalued or undervalued?
Valuation metrics for GSAC: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is GSAC's AI grade for 2026?
Our dual AI analysis gives Gelstat Corp. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is GSAC's free cash flow?
Gelstat Corp.'s operating cash flow is N/A, with capital expenditures of N/A.
How does GSAC compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).